🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Treatment Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Viewers are urged to contact these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Worries

However, physicians and chemists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could lead to individuals administering products of unknown origin.

Some experts stated the demand for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and customer laws, risking fines, legal action or prison.

Platform Response and Content Removal

Based on the social media company, the platform has taken down violative material and banned associated hashtags and search suggestions. The company stated it was dedicated to keeping the service safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Research also found groups with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with numerous of users, populated with photos of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at home.

After moments of joining one group, a seller posted contact information, where most purchases occur. The vendor sent an guidebook and promised shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.

Item Details and Costs

Inside these communities, messages display black plastic packages with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram stated it actively monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they cannot confirm. Although the science behind this drug is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has already seen individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to potentially serious health risks”.